Epstein-Barr virus (EBV) is an oncogenic virus that is closely associated with development of several malignancies, including Hodgkin lymphoma (HL), Burkitt lymphoma, nasopharyngeal carcinoma (NPC), and EBV+ gastric carcinoma (GC). EBV-DNA can be detected in approximately 90% of NPC tissues, where the virus express a limited subset of genes; these include EBV nuclear antigen 1 (EBNA1), latent membrane protein 1 (LMP1), and LMP2. Although massive EBV-specific cytotoxic T cells (CTLs) can be detected in NPC, they are unable to eliminate EBV-infected cells in vivo. 1,2 Furthermore, our previous study found high-density infiltration of CD8+ T cells in NPC tissues have lower overall survival (OS) and progression-free survival. 3 We speculated that is related immune evasion in tumor. Several immune evasion mechanisms have been proposed, one current focus in attempt to understand this phenomenon is regulatory T cells (Tregs).